Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAPOVER: Signal Transduction Pathway Analysis in Ovarian Cancer
NCT03458221Phase 3Recruiting
- Sponsor
- Gynaecologisch Oncologisch Centrum Zuid
- Start
- Jan 2023
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole, bicalutamide, everolimus, itraconazole in ovarian cancer, sponsored by Gynaecologisch Oncologisch Centrum Zuid. Started Jan 2023; status: recruiting.
02
Drugs
letrozolebicalutamideeverolimusitraconazole
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03458221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03458221.